To develop an efficient and safe COVID-19 cocktail vaccine, an “Sp/Nsp cocktail vaccine”, which mixes a structural protein(s) (Sp, such as S protein) and a non-structural protein(s) (Nsp, such as nsp3) could induce more favorable protective immune responses than vaccines expressing a structural protein(s). The gene discussed is TFF2; the disease is COVID-19.